0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Ionic Channels Involved in the LHRH and SRIF Release from Rat Mediobasal Hypothalamus

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A superfusion system was used in order to investigate the ionic requirements of luteinizing hormone releasing hormone (LHRH) and somatostatin (SRIF) release from mediobasal hypothalamic (MBH) slices of male adult rats. Slices were superfused with Hepes-buffered Locke medium at 37 °C in an atmosphere of Ch 95%–CO2 5% for 1 h. Bacitracin (2 × 10<sup>–5</sup> M) was added to the medium to prevent enzymatic degradation of neuropeptides. Depolarizing agents such as potassium (K<sup>+</sup>) or veratridine stimulated LHRH and SRIF release in a dose-dependent manner. Maximal effect was obtained with K<sup>+</sup> 56 m M and veratridine 50 µ M. The depolarizing effect of K<sup>+</sup> 56 m M was specific and not due to the hypertonicity of the medium used. Neither Mg<sup>2+</sup> nor chlorine was needed for the spontaneous or K<sup>+</sup>-evoked release of LHRH and SRIF. The amplitude of the secretory response to K<sup>+</sup> 56 m M was related to Ca<sup>2+</sup> concentration tested in the range of 0.2–8.8 m M; maximal responses were obtained between 0.8 and 1.8 m M. Removal of Ca<sup>2+</sup> from the medium with or without replacement by Mg<sup>2+</sup>, as well as administration of voltage-sensitive Ca<sup>2+</sup> channel blockers (D-600 10<sup>–4</sup> M, Mn<sup>2+</sup> 3 mM) blocked both K<sup>+</sup> and veratridine induced neuropeptide release. When sodium channels and the ‘early’ calcium channels were blocked by tetrodotoxin (5 × 10<sup>–7</sup> M) the stimulatory effect of veratridine was completely blocked whereas the stimulation of K<sup>+</sup> was unaffected. These experiments indicate that: (1) both K<sup>+</sup> and veratridine induced-LHRH and SRIF release is a Ca2<sup>+</sup>-dependent process; (2) Ca<sup>2+</sup> concentration is critical for the amplitude of the secretory response; (3) the main Ca<sup>2+</sup> channel involved in neuropeptide release corresponds to the voltage-sensitive Ca<sup>2+</sup> channel, and (4) neither magnesium or chlorine is needed for either spontaneous or evoked release of LHRH and SRIF.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1981
          1981
          26 March 2008
          : 32
          : 3
          : 155-162
          Affiliations
          Unité 159 de Neuroendocrinologie, Centre Paul-Broca de l’Inserm, Paris, France
          Article
          123149 Neuroendocrinology 1981;32:155–162
          10.1159/000123149
          6111761
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Categories
          Original Paper

          Comments

          Comment on this article